Articles Tagged with MS

Published on:

The upcoming trials of an inexpensive drug that is already used to lower high cholesterol levels will be watched closely by doctors as well as patients who suffer from Multiple Sclerosis (MS).

In 2014, trials found that MS patients who were administered Simvastatin showed significant reductions in brain atrophy levels, compared to those who were not given the drug. That was a smaller trial with just 140 participants, but a new larger trial that is due to begin soon will focus on more than 1,100 people, and will try to confirm the results of the earlier study.

The new study will specifically look at whether the administration of Simvastatin helps reduce the progression of MS in patients. Researchers are optimistic that the drug holds plenty of potential for millions of Multiple Sclerosis sufferers in the United Kingdom – where the trial will be conducted – and around the world.

Published on:

Multiple Sclerosis, or MS, is an autoimmune inflammatory condition, which can affect the brain, spine, and nervous system. There are a wide range of symptoms that are associated with MS, and the condition itself has several degrees of severity. Therefore, qualifying for social security disability benefits for MS can be challenging.

The Social Security Administration (SSA) typically requires that a claimant must have suffered from the condition for a period of 12 months, or the condition is expected to last for at least 12 months before approving benefit payments. That, however, can be challenging in the case of Multiple Sclerosis because the symptoms tend to recur at inconsistent intervals.

For example, in the early stages of the condition, a person may suffer from a variety of symptoms, including numbness or changes in sensation in the hands and legs, swallowing problems, tremors, muscle fatigue, weakness, bowel and bladder management problems, difficulties in concentration, memory loss, blurred vision, sudden reflexes and muscular spasms. A person is said to be in “remission” during times when they are not experiencing symptoms.